We describe the mechanisms underlying the vascular contraction induced by succinate. ) [2] . Here we include data on the contractile effect of succinate in the aorta. Succinate contracted both endothelium-intact and endotheliumdenuded aortic rings isolated from male Wistar rats or C57BL/6 mice. Succinate was less effective at inducing contraction in arteries isolated from GPR91-deficient mice, when compared to its vascular effect in aortas from wild type mice. SB203508 (p38MAK inhibitor), SP600125 (JNK inhibitor) and Y27632 (Rho-kinase inhibitor) reduced succinateinduced contraction in both endothelium-intact and endotheliumdenuded rat aortic rings, while PD98059 (ERK1/2 inhibitor) did not affect succinate-induced contraction. The contractile response induced
by succinate on endothelium-intact and endothelium-denuded rat aortic rings was reduced by indomethacin (non-selective cyclooxygenase inhibitor), H7 (protein kinase C inhibitor), verapamil (Ca 2þ channel blocker) and tiron (superoxide anion scavenger 
Data
Data describes the contractile action of succninate. Fig. 1 shows representative traces of the contractile effect of succinate on endothelium-intact and endothelium-denuded aortic rings from Wistar rats and C57BL/6 or GPR91 À / À mice. The maximal contraction induced by succinate in endothelium-intact and endothelium-denuded aortas isolated from Wistar rats and C57BL/6 or GPR91-deficient mice are represented on Fig. 2 .
The effects of SB203508, SP600125, PD98059 and Y27632 on succinate-induced contraction are represented on Fig. 3 . The contractile response induced by succinate on endothelium-intact and endothelium-denuded rat aortic rings was reduced by indomethacin, H7, verapamil and tiron ( Fig. 4 ).
Experimental design, materials and methods
Male Wistar rats (230-250 g) and C57BL/6 or GPR91 À / À mice (20-25 g) were anaesthetized intraperitoneally with urethane at 1.25 g/kg (Sigma-Aldrich, St. Louis, MO, USA) and the thoracic aorta was mounted in organ chambers [1] . The contraction induced by succinate (50-130 mmol/L) was evaluated in endothelium-intact and endothelium-denuded rat aortic rings. In another set of experiments, the contractile effect of succinate (0.03-130 mmol/L) was evaluated in endotheliumintact and endothelium-denuded aortic rings from C57BL/6 and GPR91 À / À mice [2] .
In another set of experiments, the contractile response induced by succinate was evaluated in endothelium-intact or endothelium-denuded rat aortic rings incubated for 30 min with one of the following drugs: SB203508 (10 mmol/L, p38MAK inhibitor), SP600125 (10 mmol/L, JNK inhibitor), PD98059 (10 mmol/L, ERK1/2 inhibitor), Y27632 (10 mmol/L, Rho-kinase inhibitor), H7 (10 μmol/L, protein kinase C inhibitor), indomethacin (10 μmol/L, non-selective cyclooxygenase inhibitor), tiron (superoxide anion scavenger, 100 μmol/L) or verapamil (1 μmol/L, Ca 2 þ channel blocker).
Results are expressed as means 7standard errors of the mean (S.E.M.). Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Newman-Keuls multiple comparison test. P values of less than 0.05 were considered significant. 
